A new method for quickly testing blood clotting in trauma patients
Official title: A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients
Funded at Baebies, INC. · NIH-11107566 · Data updated 2026-11-12
This study is working on a new way to quickly check how well your blood clots after an injury, which is really important for trauma patients, so doctors can make fast decisions without taking too much blood.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baebies, INC. NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | April 10, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $998,891 |
| NIH project number | 4R44HL169045-02 |
| Project ID | NIH-11107566 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are trauma patients over the age of 21 who are experiencing acute bleeding and require urgent coagulation assessment.
✕Less likely to help
Patients who are not experiencing acute trauma or bleeding may not benefit from this research.
What this research studies
This research focuses on developing a low blood volume platform that allows for rapid evaluation of blood coagulation in trauma patients. It aims to address the urgent need for quick and accurate testing to manage coagulopathy, a condition that can lead to severe complications and death after injury. By using innovative technology, the research seeks to provide results faster than traditional methods, which often take too long for critical decision-making in emergency situations. The approach involves minimizing blood loss while ensuring comprehensive assessment of coagulation factors.
Why it matters
Potential benefit: If successful, this research could significantly improve the management of bleeding trauma patients, potentially reducing mortality rates and improving outcomes.
How similar studies have gone: Other research has shown promise in developing rapid coagulation tests, but this specific approach is innovative and aims to fill a critical gap in current practices.
Where this research is happening
-
Baebies, INC.
Durham, United States Active
Researchers
- Principal investigator: Pamula, Vamsee K. — Baebies, INC.
- Study coordinator: Pamula, Vamsee K.
Related research
Other NIH-funded projects on the same topics.
-
Rapid at-home-friendly test to detect live STIs and guide treatment to reduce overtreatment
A new, easy-to-use test aims to quickly tell if an STI infection is alive so patients and clinicians can treat accurately and avoid unnecessary antibiotics.
-
Quick clinic test to tell if an STI is an active infection
This project is developing a fast, in-clinic test that tells people whether a bacterial STI (like chlamydia) is a live infection that needs antibiotics so fewer people get unnecessary treatment.
-
A new way for patients to test themselves for HIV and Hepatitis B
This study is working on a simple and affordable device that lets people easily test themselves for HIV and Hepatitis B using just a drop of blood from their finger, making it easier for everyone, especially those in underserved areas, to get important health information and catch these infections early.
-
Quick low-blood test for blood clotting after traumatic injury
This project tests a fast, near-patient blood test that uses very little blood to check clotting in adults with traumatic bleeding.
-
A new test to quickly identify active sexually transmitted infections and reduce unnecessary treatments.
This study is working on a quick and easy test to help doctors tell if someone has an active sexually transmitted infection (STI) or just remnants of an old one, so they can give the right treatment and help fight against antibiotic-resistant infections.
-
A new test to tell the difference between HIV infection and vaccine effects
This study is working on new, super accurate tests to help people find out if they have HIV without mixing up the results with those from vaccines, making it easier for everyone to get tested at home or at clinics.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.